Variable Interest Entity - Summary of Revenues and Expenses Included in Consolidated Statements of Operations and Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Nov. 30, 2024		Nov. 30, 2023	Nov. 30, 2024		Nov. 30, 2023
Variable Interest Entity [Line Items]
Net sales	$ 105,175		$ 135,260	$ 289,324		$ 360,828
Cost of sales	82,830		98,918	218,878		268,281
Gross profit	22,345		36,342	70,446		92,547
Engineering and technical support	8,316		7,063	20,660		23,257
Restructuring expenses	49		101	2,378		2,168
Total operating expenses	76,561		34,075	140,906		110,200
Operating (loss) income	(54,216)		2,267	(70,460)		(17,653)
Interest and bank charges	(1,355)		(1,892)	(5,466)		(5,011)
Equity in income (loss) of equity investees	382	[1]	1,101	933	[1]	3,958
Other, net	(2,084)		156	(113)		(1,497)
Total other income (expense), net	4,242		(1,387)	13,107		(5,900)
(Loss) Income before income taxes	(49,974)	[1],[2],[3]	880	(57,353)	[1],[2],[3],[4]	(23,553)
Income tax expense	(513)		97	493		(54)
Net (loss) income	(49,461)		783	(57,846)		(23,499)
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Net sales	0		91	8		401
Cost of sales	1		90	140		295
Gross profit	(1)		1	(132)		106
Selling	0		88	(9)		305
General and administrative expense	0		399	33		1,260
Engineering and technical support	0		385	(19)		1,606
Restructuring expenses	0		0	0		27
Total operating expenses	0		872	5		3,198
Operating (loss) income	(1)		(871)	(137)		(3,092)
Interest and bank charges	(439)		(435)	(1,338)		(1,296)
Equity in income (loss) of equity investees	(478)		47	(1,843)		0
Other, net	41		0	75		47
Total other income (expense), net	(876)		(388)	(3,106)		(1,249)
(Loss) Income before income taxes	(877)		(1,259)	(3,243)		(4,341)
Income tax expense	0		0	0		0
Net (loss) income	$ (877)		$ (1,259)	$ (3,243)		$ (4,341)

[1] (b) On March 1, 2024, the Company's majority owned subsidiary, EyeLock LLC, contributed assets, including inventory and intangible assets, to a newly formed joint venture, BioCenturion LLC, which will operate a Biometrics business. For the three and nine months ended November 30, 2024, the Company accounted for its investment in BioCenturion LLC as an equity method investment (see Note 13).

[2] (a) Included in Loss before income taxes within the Automotive Electronics and Consumer Electronics segments for the three and nine months ended November 30, 2024 are impairment charges of $1,452 and $26,719, respectively, related to goodwill, and $7,436 and $7,381, respectively, related to definite-lived intangible assets. Also included in Loss before income taxes within the Consumer Electronics segment for the three and nine months ended November 30, 2024 is an impairment charge of $1,276 related to indefinite-lived intangible assets.

[3] (c) Included in Loss before income taxes within Corporate/Eliminations for the three and nine months ended November 30, 2024 is a gain on the sale of assets in the amount of $7,299 representing the sale of the Company's manufacturing facility in Lake Nona, FL (see Note 20).

[4] (d) Included in Loss before income taxes within the Consumer Electronics segment for the nine months ended November 30, 2024 is a gain on the sale of a business in the amount of $8,300 and a gain on the sale of assets in the amount of $2,154 (see Note 2).